Related Experiment Video
Updated: Feb 16, 2026

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
[New perspectives on preeclampsia]
Céline Méhats1, Francisco Miralles1, Daniel Vaiman1
1Inserm U1016, CNRS UMR8104, Institut Cochin, équipe FGTB, 24, rue du faubourg Saint-Jacques, 75014 Paris, France.
Insights
Preeclampsia, a severe pregnancy condition with hypertension and proteinuria, impacts maternal vascular health. This review covers its pathology, genetic basis, and therapeutic options for improved maternal and infant outcomes.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Cardiovascular Biology
Background:
- Preeclampsia is a significant pregnancy complication affecting maternal vascular health.
- Characterized by hypertension and proteinuria, it poses risks to both mother and child.
- Understanding its complex pathophysiology is crucial for effective management.
Purpose of the Study:
- To review recent advancements in preeclampsia pathology.
- To discuss the long-term effects on maternal vascular health.
- To explore therapeutic strategies for preeclamptic pregnancies.
Main Methods:
- Literature review of recent advances in preeclampsia research.
- Analysis of genetic, epigenetic, and immunological factors.
- Examination of cellular and animal models for pathophysiological insights.
Main Results:
- Preeclampsia involves complex genetic, epigenetic, and immunological underpinnings.
- Oxidative stress in placental and endothelial cells is a key factor.
- Various models aid in deciphering disease mechanisms.
Conclusions:
- Recent research deepens the understanding of preeclampsia's pathology.
- Long-term maternal vascular health implications require continued attention.
- Therapeutic options are evolving for better patient and infant outcomes.
Abstract:
Preeclampsia is a major, frequent and potentially severe condition of pregnancy, characterized by severe hypertension and proteinuria. In this review, we describe recent advances in understanding the pathology, and discuss the long-term impacts on maternal vascular health. Next, we describe the genetic, epigenetic and immunological basis of preeclampsia. We describe the links between preeclampsia and oxidative stress in placental (trophoblast) and endothelial cells. We mention cellular and animal models commonly used to decipher modified pathophysiological pathways in a preeclamptic pregnancy compared to a normal pregnancy. Finally, we discuss the therapeutic options, readily available or in development, to improve the monitoring of pregnancies, the health of patients and that of children born from preeclamptic pregnancies.
More Related Videos
12:02Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
12:17The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
Published on: August 2, 2017
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Mitral Valve Prolapse III: Nursing Management
Hormonal Regulation